Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA)

The discovery, synthesis, and early SAR work on a benzyl amine containing series of uPA inhibitors is reported. In this Letter we report the synthesis and evaluation of a series of non-amidine inhibitors of Urokinase Plasminogen Activator (uPA). Starting from compound 1, a significant change provide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2009-10, Vol.19 (19), p.5712-5715
Hauptverfasser: West, Christopher W., Adler, Marc, Arnaiz, Danny, Chen, Deborah, Chu, Kieu, Gualtieri, Giovanna, Ho, Elena, Huwe, Christoph, Light, David, Phillips, Gary, Pulk, Rebecca, Sukovich, Drew, Whitlow, Marc, Yuan, Shendong, Bryant, Judi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5715
container_issue 19
container_start_page 5712
container_title Bioorganic & medicinal chemistry letters
container_volume 19
creator West, Christopher W.
Adler, Marc
Arnaiz, Danny
Chen, Deborah
Chu, Kieu
Gualtieri, Giovanna
Ho, Elena
Huwe, Christoph
Light, David
Phillips, Gary
Pulk, Rebecca
Sukovich, Drew
Whitlow, Marc
Yuan, Shendong
Bryant, Judi
description The discovery, synthesis, and early SAR work on a benzyl amine containing series of uPA inhibitors is reported. In this Letter we report the synthesis and evaluation of a series of non-amidine inhibitors of Urokinase Plasminogen Activator (uPA). Starting from compound 1, a significant change provided compounds in which the amidine, binding in the S1 pocket, was replaced with a primary amine. Further modifications led to the identification of potent, selective, and orally bioavailable uPA inhibitors.
doi_str_mv 10.1016/j.bmcl.2009.08.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734043648</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X09011354</els_id><sourcerecordid>21092874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-21a56fab7f304a04efdf4743707f133a6032151ac39312b030e82793a7042d013</originalsourceid><addsrcrecordid>eNp90U1vEzEQBmALgWgI_AEOaC98SWwYf2Q_JC5RVaBSJXqgEjdr1mvDBK_d2ptI_fd1lAhuPfnyzDvWvIy95rDiwJvP29UwGb8SAP0KuhVA94QtuGpULRWsn7IF9A3UXa9-nbEXOW8BuAKlnrMz3rcg26ZbMHc52jCTI4MzxVBFV8WE3t9XA0XcI3kcvP1UhRhqnGikYCsKf2igOaZ84Dcp_qWA2VbXHvNEIf62odqYmfZYTPVhd735-JI9c-izfXV6l-zm68XP8-_11Y9vl-ebq9oo3sy14LhuHA6tk6AQlHWjU62SLbSOS4kNSMHXHI3sJRcDSLCdaHuJLSgxApdL9v6Ye5vi3c7mWU-UjfUeg427rNtyGSUb1RX57lEpOPSiK7uXTByhSTHnZJ2-TTRhutcc9KEHvdWHHvShBw2dLj2UoTen9N0w2fH_yOnwBbw9AcwGvUsYDOV_TpQwAXxd3Jejs-Vqe7JJZ0M2GDtSsmbWY6TH_vEARrGlRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21092874</pqid></control><display><type>article</type><title>Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA)</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>West, Christopher W. ; Adler, Marc ; Arnaiz, Danny ; Chen, Deborah ; Chu, Kieu ; Gualtieri, Giovanna ; Ho, Elena ; Huwe, Christoph ; Light, David ; Phillips, Gary ; Pulk, Rebecca ; Sukovich, Drew ; Whitlow, Marc ; Yuan, Shendong ; Bryant, Judi</creator><creatorcontrib>West, Christopher W. ; Adler, Marc ; Arnaiz, Danny ; Chen, Deborah ; Chu, Kieu ; Gualtieri, Giovanna ; Ho, Elena ; Huwe, Christoph ; Light, David ; Phillips, Gary ; Pulk, Rebecca ; Sukovich, Drew ; Whitlow, Marc ; Yuan, Shendong ; Bryant, Judi</creatorcontrib><description>The discovery, synthesis, and early SAR work on a benzyl amine containing series of uPA inhibitors is reported. In this Letter we report the synthesis and evaluation of a series of non-amidine inhibitors of Urokinase Plasminogen Activator (uPA). Starting from compound 1, a significant change provided compounds in which the amidine, binding in the S1 pocket, was replaced with a primary amine. Further modifications led to the identification of potent, selective, and orally bioavailable uPA inhibitors.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2009.08.008</identifier><identifier>PMID: 19703768</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Administration, Oral ; Amidines - chemistry ; Analytical, structural and metabolic biochemistry ; Animals ; Benzylamines - chemistry ; Binding Sites ; Biological and medical sciences ; Crystallography, X-Ray ; Enzymes and enzyme inhibitors ; Fundamental and applied biological sciences. Psychology ; Humans ; Hydrolases ; Medical sciences ; Miscellaneous ; Pharmacology. Drug treatments ; Rats ; Serine protease ; Serine Proteinase Inhibitors - administration &amp; dosage ; Serine Proteinase Inhibitors - chemical synthesis ; Serine Proteinase Inhibitors - chemistry ; Structure-Activity Relationship ; uPA ; Urokinase ; Urokinase-Type Plasminogen Activator - antagonists &amp; inhibitors ; Urokinase-Type Plasminogen Activator - metabolism</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2009-10, Vol.19 (19), p.5712-5715</ispartof><rights>2009 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-21a56fab7f304a04efdf4743707f133a6032151ac39312b030e82793a7042d013</citedby><cites>FETCH-LOGICAL-c416t-21a56fab7f304a04efdf4743707f133a6032151ac39312b030e82793a7042d013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2009.08.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22002015$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19703768$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>West, Christopher W.</creatorcontrib><creatorcontrib>Adler, Marc</creatorcontrib><creatorcontrib>Arnaiz, Danny</creatorcontrib><creatorcontrib>Chen, Deborah</creatorcontrib><creatorcontrib>Chu, Kieu</creatorcontrib><creatorcontrib>Gualtieri, Giovanna</creatorcontrib><creatorcontrib>Ho, Elena</creatorcontrib><creatorcontrib>Huwe, Christoph</creatorcontrib><creatorcontrib>Light, David</creatorcontrib><creatorcontrib>Phillips, Gary</creatorcontrib><creatorcontrib>Pulk, Rebecca</creatorcontrib><creatorcontrib>Sukovich, Drew</creatorcontrib><creatorcontrib>Whitlow, Marc</creatorcontrib><creatorcontrib>Yuan, Shendong</creatorcontrib><creatorcontrib>Bryant, Judi</creatorcontrib><title>Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA)</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>The discovery, synthesis, and early SAR work on a benzyl amine containing series of uPA inhibitors is reported. In this Letter we report the synthesis and evaluation of a series of non-amidine inhibitors of Urokinase Plasminogen Activator (uPA). Starting from compound 1, a significant change provided compounds in which the amidine, binding in the S1 pocket, was replaced with a primary amine. Further modifications led to the identification of potent, selective, and orally bioavailable uPA inhibitors.</description><subject>Administration, Oral</subject><subject>Amidines - chemistry</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Animals</subject><subject>Benzylamines - chemistry</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Crystallography, X-Ray</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Hydrolases</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Serine protease</subject><subject>Serine Proteinase Inhibitors - administration &amp; dosage</subject><subject>Serine Proteinase Inhibitors - chemical synthesis</subject><subject>Serine Proteinase Inhibitors - chemistry</subject><subject>Structure-Activity Relationship</subject><subject>uPA</subject><subject>Urokinase</subject><subject>Urokinase-Type Plasminogen Activator - antagonists &amp; inhibitors</subject><subject>Urokinase-Type Plasminogen Activator - metabolism</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90U1vEzEQBmALgWgI_AEOaC98SWwYf2Q_JC5RVaBSJXqgEjdr1mvDBK_d2ptI_fd1lAhuPfnyzDvWvIy95rDiwJvP29UwGb8SAP0KuhVA94QtuGpULRWsn7IF9A3UXa9-nbEXOW8BuAKlnrMz3rcg26ZbMHc52jCTI4MzxVBFV8WE3t9XA0XcI3kcvP1UhRhqnGikYCsKf2igOaZ84Dcp_qWA2VbXHvNEIf62odqYmfZYTPVhd735-JI9c-izfXV6l-zm68XP8-_11Y9vl-ebq9oo3sy14LhuHA6tk6AQlHWjU62SLbSOS4kNSMHXHI3sJRcDSLCdaHuJLSgxApdL9v6Ye5vi3c7mWU-UjfUeg427rNtyGSUb1RX57lEpOPSiK7uXTByhSTHnZJ2-TTRhutcc9KEHvdWHHvShBw2dLj2UoTen9N0w2fH_yOnwBbw9AcwGvUsYDOV_TpQwAXxd3Jejs-Vqe7JJZ0M2GDtSsmbWY6TH_vEARrGlRQ</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>West, Christopher W.</creator><creator>Adler, Marc</creator><creator>Arnaiz, Danny</creator><creator>Chen, Deborah</creator><creator>Chu, Kieu</creator><creator>Gualtieri, Giovanna</creator><creator>Ho, Elena</creator><creator>Huwe, Christoph</creator><creator>Light, David</creator><creator>Phillips, Gary</creator><creator>Pulk, Rebecca</creator><creator>Sukovich, Drew</creator><creator>Whitlow, Marc</creator><creator>Yuan, Shendong</creator><creator>Bryant, Judi</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20091001</creationdate><title>Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA)</title><author>West, Christopher W. ; Adler, Marc ; Arnaiz, Danny ; Chen, Deborah ; Chu, Kieu ; Gualtieri, Giovanna ; Ho, Elena ; Huwe, Christoph ; Light, David ; Phillips, Gary ; Pulk, Rebecca ; Sukovich, Drew ; Whitlow, Marc ; Yuan, Shendong ; Bryant, Judi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-21a56fab7f304a04efdf4743707f133a6032151ac39312b030e82793a7042d013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Administration, Oral</topic><topic>Amidines - chemistry</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Animals</topic><topic>Benzylamines - chemistry</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Crystallography, X-Ray</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Hydrolases</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Serine protease</topic><topic>Serine Proteinase Inhibitors - administration &amp; dosage</topic><topic>Serine Proteinase Inhibitors - chemical synthesis</topic><topic>Serine Proteinase Inhibitors - chemistry</topic><topic>Structure-Activity Relationship</topic><topic>uPA</topic><topic>Urokinase</topic><topic>Urokinase-Type Plasminogen Activator - antagonists &amp; inhibitors</topic><topic>Urokinase-Type Plasminogen Activator - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>West, Christopher W.</creatorcontrib><creatorcontrib>Adler, Marc</creatorcontrib><creatorcontrib>Arnaiz, Danny</creatorcontrib><creatorcontrib>Chen, Deborah</creatorcontrib><creatorcontrib>Chu, Kieu</creatorcontrib><creatorcontrib>Gualtieri, Giovanna</creatorcontrib><creatorcontrib>Ho, Elena</creatorcontrib><creatorcontrib>Huwe, Christoph</creatorcontrib><creatorcontrib>Light, David</creatorcontrib><creatorcontrib>Phillips, Gary</creatorcontrib><creatorcontrib>Pulk, Rebecca</creatorcontrib><creatorcontrib>Sukovich, Drew</creatorcontrib><creatorcontrib>Whitlow, Marc</creatorcontrib><creatorcontrib>Yuan, Shendong</creatorcontrib><creatorcontrib>Bryant, Judi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>West, Christopher W.</au><au>Adler, Marc</au><au>Arnaiz, Danny</au><au>Chen, Deborah</au><au>Chu, Kieu</au><au>Gualtieri, Giovanna</au><au>Ho, Elena</au><au>Huwe, Christoph</au><au>Light, David</au><au>Phillips, Gary</au><au>Pulk, Rebecca</au><au>Sukovich, Drew</au><au>Whitlow, Marc</au><au>Yuan, Shendong</au><au>Bryant, Judi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA)</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>19</volume><issue>19</issue><spage>5712</spage><epage>5715</epage><pages>5712-5715</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>The discovery, synthesis, and early SAR work on a benzyl amine containing series of uPA inhibitors is reported. In this Letter we report the synthesis and evaluation of a series of non-amidine inhibitors of Urokinase Plasminogen Activator (uPA). Starting from compound 1, a significant change provided compounds in which the amidine, binding in the S1 pocket, was replaced with a primary amine. Further modifications led to the identification of potent, selective, and orally bioavailable uPA inhibitors.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>19703768</pmid><doi>10.1016/j.bmcl.2009.08.008</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2009-10, Vol.19 (19), p.5712-5715
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_734043648
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Administration, Oral
Amidines - chemistry
Analytical, structural and metabolic biochemistry
Animals
Benzylamines - chemistry
Binding Sites
Biological and medical sciences
Crystallography, X-Ray
Enzymes and enzyme inhibitors
Fundamental and applied biological sciences. Psychology
Humans
Hydrolases
Medical sciences
Miscellaneous
Pharmacology. Drug treatments
Rats
Serine protease
Serine Proteinase Inhibitors - administration & dosage
Serine Proteinase Inhibitors - chemical synthesis
Serine Proteinase Inhibitors - chemistry
Structure-Activity Relationship
uPA
Urokinase
Urokinase-Type Plasminogen Activator - antagonists & inhibitors
Urokinase-Type Plasminogen Activator - metabolism
title Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T14%3A39%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20orally%20bioavailable,%20non-amidine%20inhibitors%20of%20Urokinase%20Plasminogen%20Activator%20(uPA)&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=West,%20Christopher%20W.&rft.date=2009-10-01&rft.volume=19&rft.issue=19&rft.spage=5712&rft.epage=5715&rft.pages=5712-5715&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2009.08.008&rft_dat=%3Cproquest_cross%3E21092874%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21092874&rft_id=info:pmid/19703768&rft_els_id=S0960894X09011354&rfr_iscdi=true